Website & contact details
- Group website
- The site of this company’s group or brand.
Crescent Pharma Otc Limited
- Incorporated
- 6 March 2000 (26 years)
- Previously known as
- Anglian Pharma Sales & Marketing Limited (until 22 October 2013)Choqs 344 Limited (until 24 March 2000)
- Industry
- Wholesale of pharmaceutical goods (46460)
- Owned by
- Accounts type
- Audit exemption subsidiary
- Region
- South East
- Address
- Key HouseSarum HillBasingstokeRG21 8SR
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 15 January 2027
- Last conf. stmt
- 1 January 2026
Charges
- Total
- 5
- Outstanding
- 2
- Part satisfied
- 0
- Satisfied
- 3
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 7 June 2023
British
Born August 1991 (35)
Director · Appointed 7 June 2023
British
Born December 1989 (36)
Director · Appointed 19 March 2007
British
Born November 1965
Officer history (12 former)
7 June 2023
7 June 2023
31 December 2020
1 February 2012
19 March 2007
19 March 2007
19 March 2007
19 March 2007
19 March 2007
19 March 2007
19 March 2007
6 January 2003
6 January 2003
6 January 2003
6 January 2003
6 January 2003
31 January 2001
Resigned Fielder, Christopher Robert Duncan as Director
24 March 2000
24 March 2000
24 March 2000
24 March 2000
Appointed Fielder, Christopher Robert Duncan as Director
24 March 2000
24 March 2000
24 March 2000
6 March 2000
6 March 2000
6 March 2000
Ownership 2 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 15 February 2024
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Limited Company By Shares
Reg. no. 04750933
Mohammed Khalid Aldoori
Individual · Notified 6 April 2016
Right to appoint and remove directors
British
Born November 1965
Group structure 6 companies
Ownership group derived from the Companies House PSC register
Crescent Manufacturing Limited Owns 75–100% of shares
Crescent Medical UK Limited Owns 75–100% of shares
Crescent Pharma Limited Owns 75–100% of shares
Crescent Pharma Otc Limited This company Owns 75–100% of shares
Thorpe Laboratories Limited Owns 75–100% of shares
Financials
Figures from 2021 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £616,735
- up £56,783 (10%)
- 2020: £559,952 in the 2021 accounts
- Cash
- £550,087
- down £1,715,196 (76%)
- Profit
- £56,783
- down £331,794 (85%)
- 2020: £388,577 in the 2021 accounts
- Employees
- 1
- no change
- Debt Ratio
- 15%
- Current Ratio
- 6.7x
- Return on Equity
- 9%
Trend
Net Assets
Balance sheet detail
| 2021 | 2020 | |
|---|---|---|
| Fixed Assets | £313 | £846 |
| Current Assets | £723,831 | £2,740,023 |
| Debtors | £173,744 | £399,195 |
| Cash | £550,087 | £2,265,283 |
| Creditors (< 1 year) | £107,407 | £2,220,110 |
| Net Current Assets | £616,424 | £519,913 |
| Net Assets | £616,735 | £520,859 |
| Shareholder Funds | £616,735 | £520,859 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 22 October 2026 | Other filing | |||
| 22 October 2026 | Other filing | |||
| 22 October 2026 | Accounts filing | |||
| 22 October 2026 | Audit exemption subsidiary accounts | 31 December 2025 | ||
| 14 January 2026 | Confirmation statement with no updates | 1 January 2026 |
Some other companies at this address
Other companies in this industry
Harrow
Oxford
Borehamwood
Stoke-On-Trent
Manchester
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →